PMCT
PharmaCountry
+ Create
EN
Demands
Home
Products
Services
Jobs
Seekers
No categories for this tab
Retry
Regulatory Updates | Pharmacountry Insights
Home
/
Insights
/
Regulatory Updates
Regulatory Updates
FDA, EMA, TGA and global regulatory developments
#ACARBOSE
×
Daily News
Market Analysis
Research & Reports
Regulatory Updates
UPDATED
Regulatory Updates
Sep 9, 2026
•
3 min read
FDA Approves IMPAX Labs' ACARBOSE Oral Tablets (ANDA 078441)
FDA granted approval for IMPAX Labs' ANDA 078441, authorizing prescription oral tablets of ACARBOSE in 25 mg, 50 mg, and 100 mg strengths.